Today's Date: September 23, 2021
Strategic Objectives Co-Founders Awarded CPRS National's 2021 Entrepreneurial Leadership Award   •   Ovarian CanceRx: New Innovative Clinical Research Effort Seeks to Accelerate the Development of New Treatments for Deadliest Gyn   •   In Memoriam: Pacific Islanders in Communication Mourns the Passing of Beloved Executive Director, Leanne Ferrer   •   HERO Beverage Co. Launches a Line of Coffee Honoring the Late Chris Kyle   •   DKT International Publishes 2020 Contraceptive Social Marketing Statistics   •   A New 3D Kirby Game, First Look at Bayonetta 3 and a Massive Expansion for MONSTER HUNTER RISE Highlight the Latest Nintendo Dir   •   Graduates of the DS4A / Empowerment Program Can Now Earn Credits Toward a Degree at Miami Dade College   •   Federal Title & Escrow Company Donates to Women's Organization Working to End Homelessness in Nation's Capital   •   Chicago Children's Museum Launches Construction Of Its Newest Exhibit, Moen Presents Water City   •   Virginia GrandDriver Goes Retro with New 80's-Themed Workout Series Aimed to Help Older Drivers Get Fit, Drive Safely, and Have   •   32 NFL Quarterbacks Unite to Honor Bart Starr and Raise Funds for Pediatric Cancer Research   •   The Boston Globe To Launch "Black News Hour," Hosting Boston Mayoral Candidates For Debut Episode September 24th   •   Athletic Brewing, the Brewer Leading the Non-Alcoholic Craft Beer Movement, Takes Home Top Awards at Three Major Beer Competitio   •   At-Risk Shelter Dogs Given Another Chance at Life with Veterans and Inmates through Marley's Mutts ® Pawsitive Change Progra   •   Barron’s Names Edelman Financial Engines America’s Top Independent Registered Investment Advisor   •   Skechers Announces Updated Fireside Chat Time at the Morgan Stanley Virtual Global Sporting Goods Day   •   DeAndre Hopkins, NFL FLAG, Arizona Cardinals Debut DeAndre Hopkins NFL FLAG Football   •   PEWIN Announces 2021 Annual LP/GP Awards Recipients   •   Naples Soap Co. Signs Lease for a New Store Location in Kissimmee, Fla.   •   SICO Paint by PPG Unveils 2022 Colour of the Year: Cool Current
Bookmark and Share

Virios Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Thursday, August 12, 2021

ATLANTA , August 05 /Businesswire/ - Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, announced today that its second quarter 2021 financial results will be reported on Thursday, August 12, 2021 before the open of the financial markets. Management will also host a webcast and conference call on August 12, 2021 at 8:30 a.m. ET to discuss the results and provide a corporate update.

The live and archived webcast of the call may be accessed on the Virios Therapeutics website under the Investors section: Events and Presentations. The live call can also be accessed by dialing (844) 602-0380 (domestic) or (862) 298-0970 (international) and asking to be connected to the "Virios Therapeutics Conference Call".

About Virios Therapeutics

Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, such as fibromyalgia (“FM”). Immune responses related to the activation of tissue resident Herpes Simplex Virus-1 (“HSV-1”) have been postulated as a potential root cause triggering and/or sustaining chronic illnesses such as FM, irritable bowel disease (“IBS”), chronic fatigue syndrome and other functional somatic syndromes, all of which are characterized by waxing and waning symptoms with no obvious etiology. Our lead development candidate (“IMC-1”) is a novel, proprietary, fixed dose combination of famciclovir and celecoxib designed to synergistically suppress HSV-1 replication, with the end goal of reducing virally promoted disease symptoms.

Evidence of IMC-1’s efficacy on a broad spectrum of FM outcome measures was previously demonstrated in a Phase 2a clinical trial. These trial results are suggestive that IMC-1 may represent a new and novel treatment for fibromyalgia. IMC-1 has been granted fast track designation by the FDA and is currently being tested in a multi-center, randomized, double-blind, placebo-controlled Phase 2b trial (“FORTRESS”) designed to set the stage for registrational studies. The company is led by an executive team highly experienced in the successful development and commercialization of novel therapies. For more information, please visit www.virios.com.

Forward-Looking Statements

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” "will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Virios Therapeutics’ current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the completion and timing of the Phase 2b trial. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Virios Therapeutics, Inc. (VIRI) undertakes no duty to update such information except as required under applicable law.


STORY TAGS: United States, North America, Georgia, Biotechnology, General Health, Women, Consumer, Health, Webcast, Conference Call, Advisory, Earnings,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News